Clinical Trial Update: High-Intensity Inpatient MDMA-Assisted Psychotherapy for PTSD [Phase 2]

View source ↗

Summary

Phase 2 study of high-intensity inpatient MDMA-assisted psychotherapy for Posttraumatic Stress Disorder is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Drugs mentioned

• MDMA (3,4-methylenedioxymethamphetamine)

Snippet

Sponsor: ARQ National Psychotrauma Centre | Conditions: Posttraumatic Stress Disorder (PTSD) | Phase 2 | Status: ENROLLING_BY_INVITATION